![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Das Gupta R. Guest J.F.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.20, Iss.7, 2002-01, pp. : 475-484
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Influenza vaccination programme worth it in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hib vaccination programme `highly cost-beneficial' in the US
Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hib vaccination programme `highly cost-beneficial' in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 386, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Employee influenza vaccination programme worth it in Columbia?
Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. :